0000950170-25-005636.txt : 20250115
0000950170-25-005636.hdr.sgml : 20250115
20250115083002
ACCESSION NUMBER: 0000950170-25-005636
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20250115
DATE AS OF CHANGE: 20250115
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Candel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001841387
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 522214851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40629
FILM NUMBER: 25531229
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 450
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 617-916-5445
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 450
CITY: NEEDHAM
STATE: MA
ZIP: 02494
FORMER COMPANY:
FORMER CONFORMED NAME: Candel Therapeutics, Inic.
DATE OF NAME CHANGE: 20210120
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tak Paul Peter
CENTRAL INDEX KEY: 0001873905
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: CANDEL THERAPEUTICS, INC.
STREET 2: 117 KENDRICK ST SUITE 450
CITY: NEEDHAM
STATE: MA
ZIP: 02494
144
1
primary_doc.xml
144
0001873905
XXXXXXXX
LIVE
0001841387
CANDEL THERAPEUTICS, INC.
001-40629
117 Kendrick St
Suite 450
Needham
MA
02494
617-916-5445
Tak Paul Peter
Officer
Director
Common Stock
Morgan Stanley Smith Barney
2000 Westchester Ave
Purchase
NY
10577-2530
19970
156564.8
32475537
01/15/2025
NASDAQ
Common Stock
11/26/2023
RSU Award
Candel Therapeutics, Inc.
N
19970
11/26/2023
Not Applicable
Y
The sales reported on this Form 144 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.
01/15/2025
/s/ Charles Schoch, as Attorney-in-Fact for Paul Peter Tak